Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha B Leighl

Showing results (1-10 of 320) with videos related to

Pageof 32
Sort By:
The New England Journal of Medicine|August 14, 2024
Osimertinib in Stage III <i>EGFR</i>-Mutated NSCLC - Game, Set, MatchNatasha B Leighl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2015
Sunitinib: the next advance in small-cell lung cancer?Natasha B Leighl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2021
Meeting Immunotherapy Resistance in Lung CancerNatasha B Leighl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Positron emission tomography use and stage migration in lung cancer: a false sense of accomplishment?Natasha B Leighl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Targeting the phosphatidylinosital 3-kinase, Akt, and mammalian target of rapamycin pathway in non-small cell lung cancerSinead Cuffe, Natasha B Leighl
Cancer|May 5, 2020
Molecular testing for lung adenocarcinoma: Is it time to adopt a "plasma-first" approach?Maisam Makarem, Natasha B Leighl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Reply to G. Spitzer and M.A. SocinskiAlona Zer, Natasha B Leighl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2014
Second-line therapy in non-small-cell lung cancer: the DELTA between different genotypes widensAlona Zer, Natasha B Leighl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Targeting vascular endothelial growth factor in lung cancerArman Hasani, Natasha B Leighl
Journal of Oncology Practice|December 21, 2016
Curing Early-Stage Lung Cancer: Is There an Easy Way Out?Eiran Warner, Natasha B Leighl
Pageof 32

Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
The New England Journal of Medicine|August 14, 2024
Osimertinib in Stage III <i>EGFR</i>-Mutated NSCLC - Game, Set, MatchNatasha B Leighl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2015
Sunitinib: the next advance in small-cell lung cancer?Natasha B Leighl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2021
Meeting Immunotherapy Resistance in Lung CancerNatasha B Leighl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Positron emission tomography use and stage migration in lung cancer: a false sense of accomplishment?Natasha B Leighl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Targeting the phosphatidylinosital 3-kinase, Akt, and mammalian target of rapamycin pathway in non-small cell lung cancerSinead Cuffe, Natasha B Leighl
Cancer|May 5, 2020
Molecular testing for lung adenocarcinoma: Is it time to adopt a "plasma-first" approach?Maisam Makarem, Natasha B Leighl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Reply to G. Spitzer and M.A. SocinskiAlona Zer, Natasha B Leighl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2014
Second-line therapy in non-small-cell lung cancer: the DELTA between different genotypes widensAlona Zer, Natasha B Leighl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Targeting vascular endothelial growth factor in lung cancerArman Hasani, Natasha B Leighl
Journal of Oncology Practice|December 21, 2016
Curing Early-Stage Lung Cancer: Is There an Easy Way Out?Eiran Warner, Natasha B Leighl
Pageof 32